Glipizide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
11788-120 -
Package NDC
11788-120-01 -
Package NDC
11788-120-05 -
Package NDC
11788-120-10 -
Application number
ANDA074305 -
SPL ID
a60bf08d-80c5-4145-9a22-e08e424f1f95 -
SPL set ID
2110a7ca-3c1f-4db4-9211-65546b74533c -
UNII
X7WDT95N5C -
RxCUI
310488 -
RxCUI
310490 -
RxCUI
379804
What the source publishes
- Labeler
- AiPing Pharmaceutical, Inc.
- Active ingredients
- Glipizide
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Glipizide",
"splId": "a60bf08d-80c5-4145-9a22-e08e424f1f95",
"labels": [
{
"setId": "2110a7ca-3c1f-4db4-9211-65546b74533c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2110a7ca-3c1f-4db4-9211-65546b74533c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2110a7ca-3c1f-4db4-9211-65546b74533c"
}
],
"routes": [
"ORAL"
],
"labeler": "AiPing Pharmaceutical, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (11788-120-01)",
"package_ndc": "11788-120-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20261009"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (11788-120-05)",
"package_ndc": "11788-120-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20261009"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (11788-120-10)",
"package_ndc": "11788-120-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20261009"
}
],
"productId": "11788-120_a60bf08d-80c5-4145-9a22-e08e424f1f95",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "11788-120",
"deaSchedule": null,
"genericName": "Glipizide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GLIPIZIDE",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA074305",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20261009",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175608",
"M0020795"
],
"upc": [
"0311788118109"
],
"unii": [
"X7WDT95N5C"
],
"rxcui": [
"310488",
"310490",
"379804"
],
"spl_set_id": [
"2110a7ca-3c1f-4db4-9211-65546b74533c"
],
"pharm_class_cs": [
"Sulfonylurea Compounds [CS]"
],
"pharm_class_epc": [
"Sulfonylurea [EPC]"
],
"manufacturer_name": [
"AiPing Pharmaceutical, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:11788-120_a60bf08d-80c5-4145-9a22-e08e424f1f95"